000 01330 a2200373 4500
005 20250517235020.0
264 0 _c20181212
008 201812s 0 0 eng d
022 _a0888-5109
024 7 _a10.4140/TCP.n.2018.521
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aNguyen, Hannah K
245 0 0 _aAnticoagulant Use in High Stroke-Risk Patients With Nonvalvular Atrial Fibrillation.
_h[electronic resource]
260 _bThe Consultant pharmacist : the journal of the American Society of Consultant Pharmacists
_cSep 2018
300 _a521-530 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aAnticoagulants
_xtherapeutic use
650 0 4 _aAtrial Fibrillation
_xdrug therapy
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aRetrospective Studies
650 0 4 _aStroke
_xetiology
700 1 _aHumber, Douglas
700 1 _aCheckoway, Harvey
700 1 _aBlanchard, Daniel
700 1 _aWatanabe, Jonathan H
773 0 _tThe Consultant pharmacist : the journal of the American Society of Consultant Pharmacists
_gvol. 33
_gno. 9
_gp. 521-530
856 4 0 _uhttps://doi.org/10.4140/TCP.n.2018.521
_zAvailable from publisher's website
999 _c28806119
_d28806119